shock - PowerPoint PPT Presentation

About This Presentation
Title:

shock

Description:

Title: PowerPoint Presentation Last modified by: Created Date: 1/1/1601 12:00:00 AM Document presentation format: Other titles – PowerPoint PPT presentation

Number of Views:182
Avg rating:3.0/5.0
Slides: 83
Provided by: courseSdu99
Category:

less

Transcript and Presenter's Notes

Title: shock


1
(No Transcript)
2
shock

3
  • ??Introduction
  • 1. 1731. Le Dran French
  • He first used shock to describe
    the severe condition of
  • the patient of hurt.

4
  • 2. 1895 Warren
  • describe the clinical manifestations
  • of shock

5
  • the face is pale or cyanosis
  • cold and clammy skin
  • rapid and thready pulse
  • oliguria
  • apathy
  • ?hypotension (Crile)

6
  • Mechanism
  • peripheral circulatory failure
  • Vascular center paralysis
  • Treatment pressor

7
  • 1960s
  • The theory of microcirculation
    Sympathetic-adrenal medulla hypersympathetic
  • 70s Cellular metabolic disturbance
  • 80s septic shock

8
  • ??Concept
  • Causes disturbance blood flow of
    microcirculation functional and
    metabolic disorders of the vital organs
  • Inadequate tissue perfusion

9
  • ??Etiology and classification of shock
  • ? Etiology
  • 1. Blood loss and body fluid loss
  • SIHR/SBP
  • SI Blood Loss
  • 0.5 10 compensation
  • 1.0 20 30 shock
  • 1.5 50 death

10
  • fluid loss vomit. diarrhea
  • collapse
  • 2.Burn/trauma pain, plasma loss burn
    shock, infection shock(late)

11
(No Transcript)
12
  • 4. Infection infectious shock
    40
  • ?endotoxicshockLPS,

  • pseudosympathetic
  • septic shock
  • hypodynamic shock low-output,cold shock
  • hyperdynamicshockhigh-output,warm shock
    (pink,dry), NO,PGI,PGE

13
  • 5. Anaphylaxis anaphylaxic shock
  • 6. Cardiogenic shock
  • 7. Neurogenic shock
  • ? classification of shock
  • 2. 1. According to the cause of shock

14
  • According to the start problem
  • 1) Hypovolemic shock
  • CVP,CO,artery blood pressure PR
  • 2) Vasogenic shock 1/5 cap opening
  • Cardiogenic shock CO CIlt2.2L/min.m2
    myoardiumgenic shock
  • non myoardiumgenic shock

15
  • ??  Periods and pathogenesis
  • ? early phase of shock (ischemic phase,
    compensatory stage, ?phase)

16
  • 1.changes of the microcirculation and its
    mechanism
  • 1)Microcirculation

17
(No Transcript)
18
(No Transcript)
19
  • contraction
  • micro-artery
  • Metarteriole
  • precapillary sphincter
  • Micro-vein

20

21
  • ?Axial flow particles flow
  • ? a. Capillaries were closed,
  • b.thoroughfare channel and Arteriovenous
    shunts are open
  • ß-receptor
  • ? perfusion flow perfusion lt flow

22
  • 2) mechanism
  • Sympathetic-adrenal-medullary system
  • Renin-angiotensin system

23
  • (1)BP sympathetic contraction of
    the
  • pain nerve
    artery and vein
  • Endotoxin
  • (2)sympathetic renal blood flow
    angiotesin

  • nervous system catecholamine

24
  • (3) endothelin (ET)
  • tissue impairment
  • (4)TXA2
  • lecithoid (??)

25
  • Opposite effectTNF,NO,lactic acid
  • 3) compensatory meaning
  • Bp self-transfusion
  • self-blood transfusion
  • CO
  • HR
  • redistribution of blood flow

26
2. Manifestations
  • ? mental status dysphoria, anxiety,
  • consciousness
  • ?skin cold and clammy, paleness of
  • complexion
  • ?cardiovascular system
  • rapid and thready pulse,
  • BP,
  • pulse pressure
  • ?urine oliguria

27
  • ? shock phase (stage of stagnant anoxia, ? phase)

28
  • 1. changes of microcirculation and its mechanism
  • 1)Microcirculation
  • Dilation
  • micro-artery.
  • Metarteriole.
  • precapillary sphincter
  • perfusion flow perfusion gt flow

29
(No Transcript)
30
  • Hemorheology
  • RBC acetylneuraminate(???) COOH
  • bring negative charge
  • sulfate(endothelium) negative charge
  • stack(??), sludge

31
(No Transcript)
32
  • 2) mechanism
  • Hypoxia
  • Histamine vasodilation congestion
  • post-capillary resistance gt pre-capillary
    resistance
  • Kinin(??) permeability blood
  • Histamine of capillaries volume
  • hypoxia of brain and heart

33
  • LPS,TNF,IL-1
  • P-selectin\E- selectin
  • ICAM-1,VCAM( endothelium )
  • WBC adhesion to endothelium cell

34
(No Transcript)
35
  • perfusion flow perfusion gt flow
  • 3)effects on body
  • a. Bp
  • b. Peripherial resistance coronary artery

36
  • 2. manifestations
  • ?mental status faint coma
  • ?skin cyanosis ,veined marble
  • ?BP heart sound slight pulse(septic
  • shock full pulse)
  • ?urine oliguria or anuria

37
  • ? Terminal shock (phase of DIC, ? stage,
  • refractory shock stage,irreversible stage,)
  • microcirculatory failure stage)
  • VSMC in wall of vessel of micromirculation(
    paralysis)

38
(No Transcript)
39
  • 1.Formation of DIC
  • 1)concentration fibrinogen
  • of blood velocity of blood flow
  • 2) acidosis damage of intrinsic blood
  • endotoxin endothelium coagulation

40
  • 3)traumatic factor ? extrinsic
    blood
  • shock (TF)
    coagulation
  • Common pathway ?

41
intrinsic blood coagulation
extrinsic blood coagulation
Cascade trigger Dominoes push over
coagulation
42
  • 4)progressive decrease of vessel reaction
  • Vessel to CA
  • H , NO VSMC KATP open Kout
    Ca2in
  • PGI

43
  • 2.changes of microcirculation
  • no perfusion , no flow , no-reflow(, WBC
    sequestration
  • 3.Effects on body
  • a.venous return to heart
  • b.Coagulation bleeding
  • c. Thrombosis and embolism

44
  • 4. Manifestations
  • Cogulation bleeding

45
  • ??Cellular metabolism alteration
  • (?) Dysfunction of Cellular metabolism
  • a. hypoxia glycolysis
    lactic acidosis
  • b. ATP Na-K pump cellular edema
  • c. metabolic acidosis

46
Cells damage


mitochondria
hypaoxia acidosis
free radical
lysosome
47
  • Experiment
  • The function of WBC leucocyte deficiency
  • Copy shock model of Rat
  • Test group 40mmHg all alive
  • Control 36 death
  • Test group 30mmHg all alive
  • Control 100 death

48
(?)Injury and apoptosis of cells 2002
WHO You ,he or she
49
  • apoptosis of cells gene regulation
    procedure death
  • Physiologic
  • pathologic

50
.
51
Activating Endonuclease degrade DNA
180-200bp oligonucleotide
52
  • (?)inflammatory mediator
  • TNF \ IL-1,2,6,8 \ TXA2
  • Anti- inflammatory mediator
  • IL-4, 10\ NO\ PGI2
  • (?)signal transduction
  • 1.NF-?B
  • 2.MAPK

53
  • ?systemic inflammatory response syndrome(SIRS)
  • 1.Introduction inflammatory medium release
  • body reaction
  • 38? lt T lt36?
  • HRgt 90?/min
  • Rgt 20?/min or PaCO2 lt4.0kPa
  • 4109/L gt WBC gt12109/L
  • two points of above SIRS

54
  • 2. Etiology and classification
  • Etiology
  • a.an-infective agent trauma,operation

  • ischemia-reperfusion
  • b. Infective agent microorganism 70
  • second hit

55
  • 3.period of SIRS
  • 1) Inflammatory cells activity
  • 2) Inflammatory mediator spillover
  • local whole body,
  • 3) SIRS/CARS imbalance
  • inflammatory mediator overflow

  • mixed antagonist
  • compensatory anti- inflammation response
    syndrom(CARS)
  • response syndrom(CARS)

56
Pathogenesis
57
multiple organ dysfunction
symdromeMODS
  • Multiple organ dysfunction syndrome
  • 1975? multiple organ failure(MOF)
  • 1991? multiple organ dysfunction
  • symdrome(MODS)

58
?????? Sequential system failure Tilney 1973
?????????????? Multiple progressive or sequential systems failure Baue 1975
??????? multiple organ failure Eiseman 1977
?????? remote organ failure Polk 1977
??????? multiple systems organ failure Fry 1980
???????? acute organ-system failure Knaus 1985
?????????? multiple organ dysfunction syndrome ACCP/SCCM 1991
59
  • 1. Concept of MODS
  • Organ function in normal ,shock ,large operation
    dysfunction /failure of two or more than
    two organs occur at the same time or one after
    another (36hs) .

60
  • 2. classification
  • a. rapid single-phase 12-36h
  • Causes dysfunction of two organs
  • b. delayed two-phase after 1-3week
  • inflammative factor second hit

61
3.important organ failure
  • 1)Acute renal failure(shock kidney)
  • early stage renal blood flow
  • functional renal failure GFR
    oliguria
  • late stage acute tubular necrosis(ATN
    )
  • parenchymal renal
    failure
  • (?????)

62
  • Grade of renal failure
  • Endogenous creatinine clearance rate
  • Pcr(plasma creatinine)
  • ? Pcr gt1.8mg/dl
  • ? Pcr gt2.5mg/dl
  • ? Pcr gt5.0mg/dl, hemodialysis(????)

63
  • 2)Acute respiratory failure(shock lung)
  • congestion
  • edema
  • thrombosis
  • atelectasis
  • formation of hyaline membrane
  • lung bleeding

64
Korea,Vietnam?? war hemodialysis
65
  • Grade of respiratory dysfunction
  • ? PaCO2 lt 33mmHg, PaO2 gt 60mmHg
  • ? PaO2 lt 60mmHg ,cyanosis
  • ? O2 50 ,breathing apparatus assist,
  • PaO2 lt 50mmHg , PaCO2

66
3)Cardiac functional diaturbance(shock
heart)
  • early stage compensation
  • late stage
  • coronary blood flow
  • acidosis?ATP
  • hyperkalemia heart
    failure
  • MDF
  • DIC of myocardium

67
  • Grade of cardial dysfunction
  • CI(cardiac index) 3.0-3.5L/min/ m2
  • ?CIlt3.0 L/min/ m2
  • ?CIlt2.0 L/min/ m2
  • ?CIlt1.5L/min/ m2 , drugs

68
  • 4) Brain function disturbance(shock brain)
  • early stage consciousness
  • late stage ischemia hypoxia
  •  
  • brain edema faint?coma

69
  • 5) Hepatic dysfunction
  • a.Kupffers cell IL-8 PMN
    sequestration
  • b.xanthine oxidase release O2 -
  • c.liver function acidosis,endotoxemia
  • icterus

70
  • Grade of liver dysfunction
  • Bilirubin
  • ?gt 2.0 mg/dl icterus
  • ? gt 4.0 mg/dl
  • ? gt 8.0 mg/dl

71
(No Transcript)
72
  • 6) Digestive tract
  • stomach ischemia, DIC, congestion

  • stress ulcer
  • intestine perfusion barrier
    function
  • microthrombus
  • bacteria\toxin get
    into blood

73
  • ?? Principle of treatment
  • 1. Restore blood volume
  • Volume of transfuse 5 times lose
  • CVP (right heart)
  • PAWP (left heart)
  • 2. Treatment of acidosis

74
  • What will be transfused?
  • Blood
  • crystalloid 0.9NaCl (sodium chloride)Saline,isot
    onic solution)
  • water 10 glucose glycogen
  • colloid plasma ,to keep osmotic pressure

75
  • 3. Application of vasoactive drugs
  • pressors drugs mortality
  • vasodilation drugs?(blood volume,CVP,Bp)
  • From Lab to bedside, from bedside to Lab
  • 4. Protection of cells hormone
  • 5. Antagonists of humoral factor
  • Benzantin histamine
  • SOD O2 -

76
Case 1
  • A 62-year-old man was brought to the emergency
    room by his son,who reported that the
    man(documented diabetes) had been eating poorly
    for 2 days and difficult to arouse that morning.
  • On exam
  • The patient would open his eyes and mumble
    incoherently in response to pain.T38.6?
    BP75/40mmHg, HR 124/min,his skin was warm.
  • Lab data
  • WBC 19.5103/mm3,oliguria, cloudy urine. Blood
    was sent for culture.

77
Treatment
  • Volume
  • Antibiotics
  • Pressors PRN

78
Case 2
  • A 67-year-old-femal arrived in the emergency room
    complaining of chest pain and severe weakness
    present for 12 hours.These symptoms had been
    preceded by several days of poor appetite,
    nausea( ??)and vomiting.
  • On exam
  • P 110/min,Bp85/50mmHg.ECG suggesting an evolving
    inferior myocardial infarction

79
Treatment
  • 1?Venodilator nitroglycerin???? (further reduces
    preload)
  • 2?Transfusion filling pressure

80
(No Transcript)
81
Referrence
  • 1.???????,?????
  • 2.Textbook of medical physiology ,tenth
    edition,Arthur C,Guyton,M.D.
  • 3.Pathophysiology,Kong Xianshou
  • 4.??????????,?????
  • 5. Pathophysiology,Chen guoqiang,Wang jianzhi

82
Write a Comment
User Comments (0)
About PowerShow.com